跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
NRA-MONTELUKAST
Authorized
STANDARD
NRA-MONTELUKAST
nora pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
aa52e11ed7cd9bd6
Company
nora pharma inc
Type
Standard
Approval Details
Approval Id
aa52e11ed7cd9bd6
Drug Approval Canada Name
NRA-MONTELUKAST
Product Name
NRA-MONTELUKAST
Status
Marketed
Status Date
2024-06-10
Original Market Date
2019-12-28
Din
02489821
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
48:10.24
Atc Original
R03DC03 MONTELUKAST
Atc Name
r 03 dc 03
Aig Number
0133823002
Company Name
nora pharma inc
Company Address
1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
MONTELUKAST (MONTELUKAST SODIUM)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
aa52e11ed7cd9bd6
Type
Standard
Back to Health Canada Approvals
NRA-MONTELUKAST - Health Canada Drug Approval Details